ONLINE MANUSCRIPT SUBMISSION
An online submission and tracking service via Internet facilitates a speedy and cost-effective submission
of manuscripts. The full manuscript has to be submitted online via Bentham's Journal Management System
(JMS) at http://jms.eurekaselect.com/journals/cte/
View Submission Instructions.
Manuscripts must be submitted by one of the authors of the manuscript, and should not be submitted by
anyone on their behalf. The principal/corresponding author will be required to submit a Copyright Letter
along with the manuscript, on behalf of all the co-authors (if any). The author(s) will confirm that the
manuscript (or any part of it) has not been published previously or is not under consideration for
publication elsewhere. Furthermore, any illustration, structure or table that has been published
elsewhere must be reported, and copyright permission for reproduction must be obtained.
For all online submissions, please provide soft copies of all the materials (main text in MS Word or
Tex/LaTeX), figures/illustrations in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw
(CDX) / ISISDraw (TGF) as separate files, while a PDF version of the entire manuscript must also be
included, embedded with all the figures/illustrations/tables/chemical structures, etc. It is advisable that the document files related to a manuscript submission should always have
the name of the corresponding author as part of the file name, i.e., “Cilli MS
text.doc”, “Cilli MS Figure 1”, etc.
It is imperative that before submission, authors should carefully proofread the files for special
characters, mathematical symbols, Greek letters, equations, tables, references and images, to ensure
that they appear in proper format.
References, figures, tables, structure, etc. should be referred in the text at the place
where they are first discussed. Figures legends/captions should also be provided.
A successful electronic submission of a manuscript will be followed by a system-generated acknowledgement
to the principal/corresponding author. Any queries therein should be addressed to [email protected]
EDITORIAL POLICIES
For journals and eBooks, the following publication policies are applied by Bentham Science
.
Peer Review
Bentham Science Publishers follows the single blind peer-review procedure for
submissions of all manuscripts to its journals, except for a selected number of patent journals
where double blind review is followed.
All submitted articles/eBook chapters are subjected to an extensive peer review in consultation with
members of the journal’s editorial board and independent external referees (usually three
reviewers). All manuscripts/chapters are assessed rapidly and the decision based on all the peer
reviewers' comments, taken by the journal’s Editor-in-Chief/eBook Editor, is then conveyed to the
author(s).
Submissions from the Editor-in-Chief will undergo independent peer-review and will be submitted to
another Editor for his decision on acceptance.
Reprints
High-quality, bound/unbound, print/e-prints can be purchased for all published articles and book
chapters.
Editorial Policies
Articles/chapters must be submitted by one of the authors of the manuscript, and should not be
submitted by anyone on their behalf. The principal/corresponding author will be required to submit a
Copyright Letter along with the manuscript, on behalf of all the co-authors (if any). The author(s)
will confirm that the manuscript (or any part of it) has not been published previously or is not
under consideration for publication elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright permission for reproduction must
be obtained.
Appeals and Complaints
Authors who wish to make a complaint should refer it to the Editor-in-Chief of the relevant journal.
For edited eBook series, the chapter contributors may direct their complaints to the Editor of the
eBook. Complaints to the Publisher may be forwarded to [email protected]
Conflict of Interest
Financial contributions to the work being reported should be clearly acknowledged, as should any
potential conflict of interest.
Plagiarism Prevention
Bentham Science uses the iThenticate software to detect instances of overlapping
and similar text in submitted manuscripts. iThenticate software checks content against a database of
periodicals, the Internet, and a comprehensive article database. It generates a similarity report,
highlighting the percentage of overlap between the uploaded article and the published material. Any
instance of content overlap is further scrutinized for suspected plagiarism according to the
publisher’s Editorial Policies. Bentham Science allows an overall similarity of 20%
for a manuscript to be considered for publication. The similarity percentage is further checked
keeping the following important points in view
Low Text Similarity
The text of every submitted manuscript is checked using the Content Tracking mode in iThenticate.
The Content Tracking mode ensures that manuscripts with an overall low percentage similarity
(but may have a higher similarity from a single source) are not overlooked. The acceptable limit
for similarity of text from a single source is 5%. If the similarity level is above
5%, the manuscript is returned to the author for paraphrasing the text and citing the
original source of the copied material.
It is important to mention that the text taken from different sources with an overall low
similarity percentage will be considered as a plagiarized content if the majority of the article
is a combination of copied material.
High Text Similarity
There may be some manuscripts with an overall low similarity percentage, but a higher percentage
from a single source. A manuscript may have less than 20% overall similarity but there may be
15% similar text taken from a single article. The similarity index in such cases is higher than
the approved limit for a single source. Authors are advised to thoroughly rephrase the similar
text and properly cite the original source to avoid plagiarism and copyright violation.
Types of Plagiarism
We all know that scholarly manuscripts are written after a thorough review of previously
published articles. It is therefore, not easy to draw a clear boundary between legitimate
representation and plagiarism. However, the following important features can assist in
identifying different kinds of plagiarized content. These are:
Reproduction of others words, sentences, ideas or findings as one’s own without proper
acknowledgement.
Text recycling, also known as self-plagiarism. It is an author’s use of a previous
publication in another paper without proper citation and acknowledgment of the original
source.
Poor paraphrasing: Copying complete paragraphs and modifying a few words without changing
the structure of original sentences or changing the sentence structure but not the
words.
Verbatim copying of text without putting quotation marks and not acknowledging the work
of the original author.
Properly citing a work but poorly paraphrasing the original text is considered as
unintentional plagiarism. Similarly, manuscripts with language somewhere between
paraphrasing and quoting are not acceptable. Authors should either paraphrase properly
or quote and in both cases, cite the original source.
Higher similarity in the abstract, introduction, materials and methods, and discussion
and conclusion sections indicates that the manuscript may contain plagiarized text.
Authors can easily explain these parts of the manuscript in many ways. However,
technical terms and sometimes standard procedures cannot be rephrased; therefore Editors
must review these sections carefully before making a decision.
Plagiarism in Published Manuscripts
Published manuscripts which are found to contain plagiarized text are retracted from the
journal’s website after careful investigation and approval by the Editor-in-Chief of the
journal. A ‘Retraction Note’ as well as a link to the original article is published on the
electronic version of the plagiarized manuscript and an addendum with retraction notification in
the particular journal.
For further details, please visit: https://www.eurekaselect.com/research-misconduct
Copyright and License
Gold Open Access (Subscription Journals and eBooks)
Accepted articles can be published online for free open access. Open access publishing provides
maximum dissemination of the article to the largest audience. All authors will be asked to
indicate whether or not they wish to pay to have their paper made freely available on
publication. If authors do not select the 'Gold Open Access' option, then their article will be
published with standard subscription-based access.
Copyright (Subscription Journals and eBooks)
Editors/Authors who contribute in a Bentham’s Journal/eBook will transfer copyright to their work
to Bentham Science Publishers. Submission of a manuscript to the respective
journals implies that all editors/authors have read and agreed to the content of the copyright
letter.
Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, it is a prerequisite to provide a formal review and
approval, or review and waiver, by an appropriate institutional review board or ethics committee,
which should be documented in the paper. For investigations undertaken on human subjects, the manner
in which the informed consent was obtained from the study participants (i.e., oral or written)
should be stated in the Methods section.
Authors are encouraged to obtain patient consent when they use confidential case material. Consent is
not necessary in the case of very brief case vignettes which do not contain identifying information
or if the case material is disguised sufficiently to prevent identification of the patient.
In obtaining consent, the author(s) should discuss the purpose(s) of publication, the possible risks
and benefits to the patient and the patient's right to withhold or withdraw consent. In the case of
a minor patient, consent should be obtained from the parent(s) or guardian(s).
Standard Protocol on Approvals, Registrations, Patients Consents & Animal Protection
All clinical investigations must be conducted according to the Declaration of Helsinki principles.
Authors must comply with the guidelines of the International Committee of Medical Journal Editors
(www.icmje.org) with regard to the patient’s consent for research
or participation in a study. Patients' names, initials, or hospital numbers must not be mentioned
anywhere in the manuscript (including figures). Editors may request that authors provide
documentation of the formal review and recommendation from the institutional review board or ethics
committee responsible for oversight of the study.
Errata and Corrections in Published Articles
Authors and readers are encouraged to notify the Editor-in-Chief if they find errors in published
content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of
a publication. In such cases the journal will publish an ERRATUM in consultation with
Editor-in-Chief and authors of the article, and/or replace or retract the article.
Article Withdrawal
Articles in Press (articles that have been accepted for publication or published as E-pub Ahead of
Schedule but which have not been formally published with volume/issue/page information) that include
errors, or are determined to violate the publishing ethics guidelines such as multiple submission,
fake claims of authorship, plagiarism, fraudulent use of data or the like, may be “Withdrawn” from
the journal. Withdrawal means that the article files are removed and replaced with a PDF stating
that the article has been withdrawn from the journal in accordance with BSP Editorial Policies.
Article Retraction
Published articles (with volume/issue/page information) which may contain infringements of
professional ethical codes, such as multiple submissions, bogus claims of authorship, plagiarism,
fraudulent use of data or the like are retracted.
A retraction note titled “Retraction: [article title]” signed by the authors and/or the
Editor-in-Chief is published in the paginated part of a subsequent issue of the journal and
listed in the contents list.
In the electronic version, a link is made to the original article.
The online article is preceded by a screen containing the retraction note. It is to this
screen that the link resolves; the reader can then proceed to the article itself.
The original article is retained unchanged with a watermark on the PDF indicating on each
page that it is “retracted.”
The HTML version of the document is removed.
Redundant (multiple) publication/ Re-publication
Abstracts and posters of conferences, results presented at meetings (for example, to inform
investigators or participants about findings), results databases (data without interpretation,
discussion, context or conclusions in the form of tables and text to describe data/information where
this is not easily presented in tabular form) are not considered prior publication.
Authors who wish to publish translations of the articles that have been published elsewhere should
ensure that they have appropriate permission(s), indicate clearly that the material has been
translated and re-published, and indicate clearly the original source of the material. The
Editor-in-Chief may request copies of related publications if he/she is concerned about overlap and
possible redundancy.
PERMISSION FOR REPRODUCTION
Permission to Reuse Bentham Content
Bentham Science has collaborated with the Copyright Clearance Center to meet our customer’s
licensing, besides rights & permission needs.
The Copyright Clearance Center’s RightsLink® service makes it faster and easier to secure permission
from Bentham Science’s journal titles. Visit
Journals by Title and locate the desired
content. Then go to the article’s abstract and click on “Rights and Permissions” to open the
RightsLink’s page. If authors can't find the content they are looking for or can't get the rights
they need, please contact us at
[email protected]
Third-Party Permissions
Authors are responsible for managing the inclusion of third-party content as an author/editor of a
work. We refer to 'third party content' as any work that authors haven't developed themselves and
have copied or adapted from other sources. Text, figures, photographs, tables, screenshots, and
other items may be included.
Unless the figure is in the public domain (copyright-free) or permitted for use under Creative Commons or other open licences, the author must get permission from the copyright holder(s).
Published/reproduced material should not be included unless written permission has been obtained from
the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the
article for publication.
Open Access Articles
Articles are licensed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0) (https://creativecommons.org/licenses/by/4.0/legalcode), which permits unrestricted distribution and reproduction in any medium, as long as the work is properly credited/attributed. For more details, please visit Open Access Policy
Disclaimer
Responsibility for the content published by Bentham Science Publishers in any of its
journals, including any opinions expressed therein, rests exclusively with the author(s) of such
content. To the maximum extent permitted by applicable law, BSP (on its own behalf, and on behalf of
its staff and members of its editorial board) disclaims responsibility for any and all injury and/or
damage (whether financial or otherwise) to persons or property, resulting directly or indirectly
from any ideas, methods, instructions or products (including errors in the same) referred to in the
content of any of BSP’s journals. Any dispute arising, including any claim shall be governed
exclusively by the laws of the United Arab Emirates, as applied in the Emirate of Sharjah.
COPYRIGHT / SELF-ARCHIVING POLICY
COPYRIGHT
Authors who publish in Bentham Science print & online journals will transfer copyright to
their work to Bentham Science Publishers. Submission of a manuscript to the respective
journals implies that all authors have read and agreed to the content of the Copyright Letter or the
Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal
have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism
is strictly forbidden, and by submitting the article for publication the authors agree that the
publishers have the legal right to take appropriate action against the authors, if plagiarism or
fabricated information is discovered. By submitting a manuscript the authors agree that the
copyright of their article is transferred to the publishers if and when the article is accepted for
publication. Once submitted to the journal, the author will not withdraw their manuscript at any
stage prior to publication.
Copyright Letter
Authors who publish in Bentham Science print & online journals will transfer copyright to their work to Bentham Science Publishers. Submission of a manuscript to the respective journals implies that all authors have read and agreed to the content of the Copyright Letter or the Terms and Conditions. It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article is accepted for publication. Once submitted to the journal, the author will not withdraw their manuscript at any stage prior to publication.
It is mandatory that a signed copyright letter also be submitted along with the manuscript by the author to whom correspondence is to be addressed. The article should not contain any such material or information that may be unlawful, defamatory, fabricated, plagiarized, or which would, if published, in any way whatsoever, violate the terms and conditions as laid down in the copyright agreement. Copyright letter can be downloaded from the journal's Web site. Download the Copyright letter.
PERMISSION FOR REPRODUCTION
Permission to Reuse Bentham Content
Bentham Science has collaborated with the Copyright Clearance Center to meet our customer’s
licensing, besides rights & permission needs.
The Copyright Clearance Center’s RightsLink® service makes it faster and easier to secure permission
from Bentham Science’s journal titles. Visit
Journals by Title and locate the desired
content. Then go to the article’s abstract and click on “Rights and Permissions” to open the
RightsLink’s page. If authors can't find the content they are looking for or can't get the rights
they need, please contact us at
[email protected]
Third-Party Permissions
Authors are responsible for managing the inclusion of third-party content as an author/editor of a
work. We refer to 'third party content' as any work that authors haven't developed themselves and
have copied or adapted from other sources. Text, figures, photographs, tables, screenshots, and
other items may be included.
Unless the figure is in the public domain (copyright-free) or permitted for use under Creative Commons or other open licences, the author must get permission from the copyright holder(s).
Published/reproduced material should not be included unless written permission has been obtained from
the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the
article for publication.
Open Access Articles
Articles are licensed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0) (https://creativecommons.org/licenses/by/4.0/legalcode), which permits unrestricted distribution and reproduction in any medium, as long as the work is properly credited/attributed. For more details, please visit Open Access Policy
SELF-ARCHIVING
By signing the Copyright Letter the authors retain the rights of self-archiving. Following are the
important features of self-archiving policy of Bentham Science journals
Authors can deposit the first draft of a submitted article on their personal websites, their
institution’s repositories or any non-commercial repository for personal use, internal
institutional use or for permitted scholarly posting.
Authors may deposit the ACCEPTED VERSION of the peer-reviewed article on their personal
websites, their institution’s repository or any non-commercial repository such as PMC, arXiv
after 12 MONTHS of publication on the journal website. In addition, an
acknowledgement must be given to the original source of publication and a link should be
inserted to the published article on the journal's/publisher’s website.
If the research is funded by NIH, Wellcome Trust or any other Open Access Mandate, authors
are allowed the archiving of published version of manuscripts in an institutional repository
after the mandatory embargo period. Authors should first contact the Editorial Office of the
journal for information about depositing a copy of the manuscript to a repository.
Consistent with the copyright agreement, Bentham Science does not allow archiving of FINAL
PUBLISHED VERSION of manuscripts.
The link to the original source of publication should be provided by inserting the DOI number
of the article in the following sentence: “The published manuscript is available at
EurekaSelect via https://www.eurekaselect.com/openurl/content.php?genre=article&doi=.
There is no embargo on the archiving of articles published under the OPEN ACCESS PLUS (GOLD
OPEN ACCESS) category. Authors are allowed deposition of such articles on institutional,
non-commercial repositories and personal websites immediately after publication on the
journal website.
DECLARATION OF INTEREST/FUNDING SOURCES
Conflict of Interest
Financial contributions and any potential conflict of interest must be clearly acknowledged under the
heading ‘Conflict of Interest’. Authors must list the source(s) of funding for the study. This
should be done for each author.
Acknowledgements
Any research assistants or other individuals who assisted with the research but are not listed as authors, such as those who carried out the literature review, produced, computerized, and analyzed the data, or helped with the language, writing, or proofreading of the article, or offered any comments or suggestions, should be acknowledged. Briefly, everyone who has contributed significantly to the improvement of the paper should be acknowledged. It is recommended to mention the "Declared None" if there is no acknowledgement for the study.
The specific requirements for authorship have been defined by the International Committee of Medical
Journal Editors (www.icmje.org). Examples of authors'
contributions are: 'designed research/study', 'performed research/study', 'contributed important
reagents', 'collected data', 'analyzed data', 'wrote paper', etc. This information must be included in the submitted manuscript as a separate paragraph under the heading 'Authors' Contribution'. The corresponding author is responsible for obtaining permission from all
co-authors for the submission of any version of the manuscript and for any changes in the
authorship.
Standard Protocol on Approvals, Registrations, Patient Consents & Animal Protection
All clinical investigations must be conducted according to the Declaration
of Helsinki principles. For all manuscripts reporting data from studies involving human
participants, formal review and approval by an appropriate institutional review board or ethics
committee is required. For research involving animals, the authors should indicate whether the
procedures followed were in accordance with the standards set forth in the eighth edition of Guide
for the Care and Use of Laboratory Animals (grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals_prepub.pdf
published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).
Research Involving Animals
Research work on animals should be carried out in accordance with the NC3Rs ARRIVE Guidelines. For
In Vivo Experiments, visit https://www.nc3rs.org.uk/arrive-guidelines
Authors must clearly state the name of the approval committee, highlighting that legal and ethical
approval was obtained prior to initiation of the research work carried out on animals, and that the
experiments were performed in accordance with the relevant guidelines and regulations stated below.
US authors should cite compliance with the US National Research Council's "Guide for the Care and Use of Laboratory
Animals"
The US Public Health Service's "Policy on Humane Care
and Use of Laboratory Animals" and "Guide
for the Care and Use of Laboratory Animals"
UK authors should conform to UK legislation under the
Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive
2010/63/EU.
Research in animals must adhere to ethical guidelines of The
International Council for Laboratory Animal Science (ICLAS) has also published ethical
guidelines.
The manuscript must clearly include a declaration of compliance with relevant guidelines
(e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive
2010/63/EU in Europe) and/or relevant permissions or licences obtained by the IUCN Policy
Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna
and Flora.
Research Involving Plants
All experimental research on plants (either cultivated or wild), must comply with international
guidelines. The manuscript must clearly include a declaration of compliance of field studies with
relevant guidelines and/or relevant permissions or licences obtained by the IUCN Policy Statement on
Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and
Flora.
Consent for Publication
If the manuscript has an individuals’ data, such as personal detail, audio-video material
etc., consent should be obtained from that individual. In case of children, consent
should be obtained from the parent or the legal guardian.
All such case reports should be followed by a proper consent prior to publishing.
A specific declaration of such approval must be made in the copyright letter and in a stand-alone
paragraph at the end of the Methods section especially in the case of human studies where inclusion
of a statement regarding obtaining the written informed consent from each subject or subject's
guardian is a must. The original should be retained by the guarantor or corresponding author.
Editors may request to provide the original forms by fax or email.
RANDOMIZED DRUG CLINICAL TRIAL STUDIES
Randomized drug clinical trial studies are biomedical or health-related interventional and/or
observational research studies conducted in phases in human beings who are randomly allocated to receive
or not receive a preventive, therapeutic, or diagnostic intervention that follows a pre-defined
protocol. The study is intended to determine the safety and efficacy of approaches to disease
prevention, diagnosis and treatment.
Authors of randomized controlled trials are encouraged to submit trial protocols along with their
manuscripts. All clinical trials must be registered (before recruitment of the first participant) at an
appropriate online public trial registry that must be independent of for-profit interest (e.g.
,www.clinicaltrials.gov). If you wish the editor(s)
to consider an unregistered trial, please explain briefly why the trial has not been registered.
All randomized clinical trials should include a flow diagram
and authors should provide a completed randomized trial
checklist (see CONSORT Flow Diagram and Checklist; www.consort-statement.org)
and a trial protocol. For further details, please visit complete
guidelines at:
http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html
Studies of diagnostic accuracy must be reported according to STARD guidelines; (http://www.stard-statement.org)
Observational studies (cohort, case-control, or cross-sectional designs) must be reported
according to the STROBE statement, and should be submitted with their protocols; (www.strobe-statement.org).
Genetic association studies must be reported according to STREGA guidelines; (www.medicine.uottawa.ca)
Systematic reviews and meta-analyses must be reported according to PRISMA guidelines; (www.prisma-statement.org)
To find the reporting guidelines see (http://
www.equator-network.org)
Important points to remember while submitting clinical trials:
Each manuscript should clearly state an objective or hypothesis; the design and methods
(including the study setting and dates, patients or participants with inclusion and exclusion
criteria, or data sources, and how these were selected for the study); the essential features of
any interventions; the main outcome measures; the main results of the study; a comment section
placing the results in context with the published literature and addressing study limitations;
and the conclusions. Data included in research reports must be original.
Trial registry name, registration identification number, and the URL for the registry should be
included at the end of the abstract and also in the space provided on the online manuscript
submission form. If your research article reports the results of a controlled health care
intervention, list the trial registry, along with the unique identifying number (Please note
that there should be no space between the letters and numbers of your trial registration
number). Studies designed for other purposes, such as to study pharmacokinetics or major
toxicity (e.g., phase 1 trials), are exempted.
All reports of randomized trials should include a section entitled “Randomization and Masking”,
within the Methods section.
The manuscript must include a statement identifying the institutional and/or licensing committee
that has approved the experiments, including any relevant details.
The SI system of units and the recommended international non-proprietary name (rINN) for drug
names must be used. Kindly ensure that the dose, route, and frequency of administration of any
drug you mention are correct.
Please ensure that the clinical trials sponsored by pharmaceutical companies follow the
guidelines on good publication practice: (http://www.gpp-guidelines.org)
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned
requirements. The author will be held responsible for false statements or failure to fulfill the
above-mentioned requirements.
AUTHORSHIP
AUTHORSHIP CRITERIA
Bentham Science Publishers requires that all
individuals listed as authors must have made a
substantial contribution to the design, performance,
analysis, or reporting of the work. The role of
authors is judged on the basis of ICMJE and COPE guidelines.
Authorship Declaration
All contributing authors are required to sign a
copyright letter, mentioning complete details,
including full name, affiliation, email address,
ORCID ID and their role in the article. After
successful electronic submission of a manuscript, a
system-generated acknowledgement will be sent to all
authors on their provided email addresses.
AUTHORS AND INSTITUTIONAL AFFILIATIONS
The Corresponding Author must provide a final list of authors at the time of submission, ensuring the correct sequence of the names of authors, which will not be considered for any addition, deletion or rearrangement after final submission of the manuscript. The
email address of the principal author should be
provided with an asterisk. However, the complete
address, business telephone numbers, fax numbers and
e-mail address of the corresponding author must be
stated to receive correspondence and galley proofs.
Bentham Science Publishers recommends that all
contributors regularly update their profiles on
SCOPUS/ORCID and other databases.
The corresponding author must have the approval of all other listed authors for the submission and publication of all versions of the manuscript.
AUTHOR IDENTIFICATION
Authors are strongly recommended to use their ORCID
ID when submitting an article for consideration.
Alternatively, they can acquire an ORCID ID via the
submission process. For more information about ORCID
IDs, visit here.
CHANGES TO AUTHORSHIP
At the time of initial submission, the finalized list
of authors in correct sequence should be provided,
which will not be changed once the publication
process has started.
If any change is essential, then it can only be done
after the approval of the Editor-in-Chief upon
receiving the following details from the
corresponding author:
- The reason for the change in the author list
and/or their sequence
- A proper justification should be provided
for changes in authorship.
- Correction of existing names should be
accompanied by a notice to the
Editor-in-Chief of the journal.
- A written confirmation from all the co-authors
is a prerequisite for any amendment or removal.
Any amendment to the authors' list will only be considered and approved by the Editor-in-Chief after complete verification. Publication of the manuscript will be withheld during consideration of the request. However, if the manuscript has already been published online, requests approved thereafter by the Editor-in-Chief will result in an erratum or corrigendum. The corresponding author is responsible for obtaining permission from all co-authors for any changes in the authorship.
Here is some advice by COPE on authorship issues. Bentham strives to follow these guidelines.
AUTHORSHIP AND AI TOOLS
Bentham Science Publishers recognizes that authors use a variety of tools for preparing articles related to their scientific works, ranging from simple ones to very sophisticated ones.
According to the COPE (Committee on Publication Ethics) guidelines, "AI tools cannot meet the requirements for authorship as they cannot take responsibility for the submitted work. As non-legal entities, they cannot assert the presence or absence of conflicts of interest nor manage copyright and license agreements".
The pertinence of such tools may vary and evolve with public opinion, due to which the use of AI-powered language tools has led to a significant debate. These tools may generate useful results, but they can also lead to errors or misleading results; therefore, it is important to know which tools were used for evaluating and interpreting a particular scientific work.
Considering the above we require that:
- The authors to report any significant use of such tools in their works, such as instruments and software along with text-to-text generative AI consistent with subject standards for methodology.
- All co-authors should sign a declaration that they take full responsibility for all of its contents, regardless of how the contents were generated. Inappropriate language, plagiarized and biased contents, errors, mistakes, incorrect references, or misleading content generated by AI language tools and the relevant results reported in scientific works are the full and shared responsibility of all the authors, including co-authors.
- AI language tools should not be listed as an author; instead, authors should follow clause (1) above.
General Advice:
Advice on how to spot authorship problems
Before Publication:
Corresponding author requests addition of extra author before publication
Corresponding author requests removal of the author before publication
After publication:
Request for addition of extra author after publication
Request for removal of author after publication
NON-AUTHOR CONTRIBUTORS
Activities such as the acquisition of funding,
general supervision of a research group or general
administrative support, writing assistance,
technical editing, language editing, and
proofreading alone do not qualify any contributor
for authorship. Such contributors may be
acknowledged individually or together as a group in
the acknowledgement section. Further details for
writing acknowledgements are available here.
Persons not meeting authorship criteria can be
acknowledged in the acknowledgement section of the
article rather than being enlisted as authors.
GUEST OR HONORARY AUTHORSHIP
All contributing authors should contribute
substantially to the article and sign the copyright
letter. Bentham Science Publishers discourages
authorship based solely on position (e.g., a
research supervisor or a departmental head). We use
COPE
guidelines for identifying any suspected
ghost, guest or gift authorship.
APPEALS AND COMPLAINTS
Generally, the editorial decisions are not reverted. However, authors who think that their manuscript was
rejected due to a misunderstanding or mistake may seek an explanation for the decision. Appeals must
give sound reasoning and compelling evidence against the criticism raised in the rejection letter. A
difference of opinion as to the interest, novelty, or suitability of the manuscript for the journal will
not be considered as an appeal. The EIC and other relevant editors will consider the appeal and the
decision thereafter taken by the journal will be deemed final. Acceptance of the manuscript is not
guaranteed even if the journal agrees to reconsider the manuscript, and the reconsideration process may
involve previous or new reviewers or editors and substantive revision.
Authors who wish to make a complaint should refer them to the Editor-in-Chief of the journal concerned.
Complaints to the Publisher may be emailed to [email protected]
PAGE CHARGES/QUICK TRACK PUBLICATION
Page Charges
No page charges will be levied to authors for the publication of their article. However, the authors
may decide for some paid-for editorial services such as open access publication and/or a faster
overall publication for their article(s).
QUICK TRACK PUBLICATION
For this journal an optional fast publication fee-based service called QUICK TRACK is available to
authors for their submitted manuscripts.
QUICK TRACK allows online publication within 2 weeks of receipt of the final approved galley proofs
from the authors. Similarly the manuscript can be published in the next forthcoming PRINT issue of
the journal. The total publication time, from date of first receipt of manuscript to its online
publication is 12 weeks, subject to its acceptance by the referees and modification (if any) by the
authors within one week.
Authors who have availed QUICK TRACK services in a BSP journal will be entitled for an exclusive 30%
discount if they again wish to avail the same services in any Bentham journal.
For more information please contact the Editorial Office by e-mail at [email protected].
REFUND POLICY
Bentham Science offers three major services related to its publications:
- Subscription services (to subscribers, institutes, libraries, customers, etc.): Involving access to published content based on certain charges for corporates, academic institutes, and individuals.
- Editorial / Author Pre-publication services (to editors, authors, etc.): Quick track processing, language editing, etc.
- Editorial / Author Post-publication Promotional Services (to authors, institutions and organizations): Open Access Plus, Animated Abstracts, Sharing PDF on KUDOS, reprints, etc.
Since these services are optional in nature and are offered for specific services rendered, hence refunds are not allowed against the availed and charged services, except under special cases.
LANGUAGE AND EDITING
Authors should seek professional assistance for the correction of grammatical, scientific, and typographical errors before submission of the revised version of the article for publication.
You may use the professional editing services of our nominated English Language editing organizations TopEdit or Eureka Science.
Please note that we accept a language certificate, only from one of the above two language editing organizations.
PROOF CORRECTIONS
Authors will receive page proofs of their accepted paper before publications. To avoid delays in
publication, proofs should be checked immediately for typographical errors and returned within
48 hours. Major changes are not acceptable at the proof stage.
The corresponding author will be solely responsible for ensuring that the revised version of the
manuscript incorpo-rating all the submitted corrections receives the approval of all the co-authors
of the manuscript.
OPEN ACCESS PLUS (GOLD OPEN ACCESS)/REPRINTS
OPEN ACCESS PLUS (GOLD OPEN ACCESS)
Bentham Science also offers authors the choice of “Open Access Plus (Gold Open Access)” publication
of articles at a fee of US$ 580 per article. This paid service allows for articles to
be disseminated to a much wider audience, on the terms of the Creative Commons Attribution
4.0 International Public License (CC-BY 4.0) (https://creativecommons.org/licenses/by/4.0/legalcode).
Authors are asked to indicate whether or not they wish to pay to have their article made more widely
available on this “Open Access Plus (Gold Open Access)” basis. Where an author does not opt-in to
this paid service, then the author’s article will be published only on Bentham Science’s standard
subscription-based access, at no additional cost to the author.
Authors who select the “Quick Track” publication option (see below) and also wish to have their
article made available on an “Open Access Plus (Gold Open Access)” basis will be entitled to a
50% discount on the “Open Access Plus (Gold Open Access)” publication fee.
For more information please contact us at e-mail: [email protected]
REPRINTS
Printed reprints and e-prints may be ordered from the Publisher prior to publication of the article.
First named authors may also order a personal print and online subscription of the journal at 50%
off the normal subscription rate by contacting the subscription department at e-mail: [email protected].
REVIEWING AND PROMPTNESS OF PUBLICATION
All papers submitted for publication are immediately subjected to preliminary editorial scrutiny by the
Editor-in-Chief regarding their suitability. The Editor-in-Chief determines if the manuscript
(a) falls within the scope of the journal and
(b) meets the editorial criteria of Bentham Science Publishers in terms of originality
and quality.
Manuscripts that appear to be suitable are then subjected to single/ double blind peer-review by, usually
two, neutral eminent experts. The services of eminent international experts are sought through
invitations to conduct the peer-review of a submitted manuscript, keeping in view the scope of the
manuscript and the expertise of the reviewers. The identity of the reviewers is not disclosed to the
authors. The anonymity of reviewers ensures objective and unbiased assessment of the manuscript by the
reviewers.
Before sending the manuscripts to reviewers, Bentham Science seeks consent from
potential reviewers about their availability and willingness to review. Correspondence between the
editorial office of the journal and the reviewers is kept confidential. The reviewers are expected to
provide their reports in a timely fashion since a prompt review leads to timely publication of a
manuscript which is beneficial not only to the authors but to the scientific community as well.
The editorial process and peer-review workflow for each journal are taken care of by a team of Senior
Editors, Editorial Board Members (EBMs) and dedicated Journal managers who have the required expertise
in their specific fields.
Bentham Science Publishers carries out independent review of all articles. The reviewers are selected
according to their expertise, from our, regularly updated, referee database.
On the basis of reviewer comments, the Editors may recommend acceptance, revision or rejection of a
manuscript.
After review of the manuscript by at least two independent experts, in addition to the views of the
Editor, the decision is relayed to the authors, which may be categorized as:
Accept without changes
Revisions Required
Reject
Bentham Science requests not to have the manuscripts peer-reviewed by those experts who
may have competing interest with the author(s) of a submitted manuscript. It is not possible for Editors
to be aware of all competing interests; it is therefore expected that the reviewers would inform the
Editor-in-Chief/Handling Editor if they notice any potential competing interest during the course of
review of a manuscript. Moreover, the reviewers are expected to inform the Editors or editorial office
of the journal if they have a conflict of interest in carrying out the review of a manuscript submitted
by any author/contributor of the manuscript.
Papers which are delayed by the authors in revision for more than 30 days are required to be re-submitted
as a new submission. Papers accepted for publication are typeset and proofs are dispatched to authors
for any corrections prior to final publication.
PLAGIARISM PREVENTION
Bentham Science Publishers uses the iThenticate software which detects instances of overlapping and similar text in
submitted manuscripts. This software checks content against a database of periodicals, the Internet, and
a comprehensive article database. It generates a similarity report, highlighting the percentage overlap
between the uploaded article and the published material. Any instance of content overlap is further
scrutinized for suspected plagiarism according to the publisher’s Editorial Policies. If the similarity
seems legitimate, the article will be proceeded for further review process; however, in cases of
superfluous plagiarism, the authors have to revise the text as per editorial instructions.
Bentham Science Publishers strictly follows the COPE guidelines to detect plagiarism; for more clear
insight, authors may refer to flowcharts provided by COPE by clicking here or by
visiting COPE website.
Low Text Similarity
The text of every submitted manuscript is checked by using the Content Tracking mode in iThenticate.
The Content Tracking mode ensures that manuscripts with an overall low percentage similarity (but
which may have a higher similarity from a single source) are not overlooked. If the similarity level
is significantly high, then the manuscript is returned to the author for paraphrasing the text and
citing the original source of the copied material.
It is important to mention that the text taken from different sources with an overall low similarity
percentage will be considered as a plagiarized content if the majority of the article is a
combination of copied material.
High Text Similarity
There may be some manuscripts with an overall low similarity percentage, but a higher percentage from
a single source. For instance, a manuscript may have less than 20% overall similarity but there may
be 15 % similar text taken from a single article; the similarity index in such cases is higher than
the approved limit for a single source. Authors are advised to thoroughly rephrase the similar text
and properly cite the original source to avoid plagiarism and copyright violation.
Types of Plagiarism
We all know that scholarly manuscripts are written after a thorough review of previously published
articles. It is therefore, not easy to draw a clear boundary between legitimate representation and
plagiarism. However, the following important features can assist in identifying different kinds of
plagiarized content. These are:
Reproduction of others words, sentences, ideas or findings as one’s own without proper
acknowledgement.
Text recycling, also known as self-plagiarism. It is an author’s use of a previous
publication in another paper without proper citation and acknowledgment of the original
source.
Paraphrasing poorly: Copying complete paragraphs and modifying a few words without changing
the structure of original sentences or changing the sentence structure but not the words.
Verbatim copying of text without putting quotation marks and not acknowledging the work of
the original author.
Properly citing a work but poorly paraphrasing the original text is considered as
unintentional plagiarism. Similarly, manuscripts with language somewhere between
paraphrasing and quoting are not acceptable. Authors should either paraphrase properly or
quote and in both cases, cite the original source.
Higher similarity in the abstract, introduction, materials and methods, and discussion and
conclusion sections indicates that the manuscript may contain plagiarized text. Authors can
easily explain these parts of the manuscript in many ways. However, technical terms and
sometimes standard procedures cannot be rephrased; therefore Editors must review these
sections carefully before making a decision.
Plagiarism in Published Manuscripts
Published manuscripts which are found to contain plagiarized text are retracted from the journal
website after careful investigation and approval by the Editor-in-Chief of the journal. A
‘Retraction Note’ as well as a link to the original article is published on the electronic version
of the plagiarized manuscript and an addendum with retraction notification in the journal concerned.
For further details, please visit: https://www.eurekaselect.com/research-misconduct
E-PUB AHEAD OF SCHEDULE
Bentham Science Publishers is pleased to offer electronic publication of accepted papers prior to
scheduled publication. These peer-reviewed papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made at the time of print publication and will be
reflected in the final electronic version of the issue. Articles ahead of schedule may be ordered by
pay-per-view at the relevant links by each article stated via the E-Pub
Ahead of Schedule
Disclaimer
Articles appearing in E-Pub Ahead-of-Schedule sections have been peer-reviewed and accepted for
publication in this journal and posted online before scheduled publication. Articles appearing here
may contain statements, opinions, and information that have errors in facts, figures, or
interpretation. Accordingly, Bentham Science Publishers, the editors , authors and
their respective employees are not responsible or liable for the use of any such inaccurate or
misleading data, opinion or information contained of articles in the E-Pub Ahead-of-Schedule.
Member of Cope